CORE 2021 – On-demand
Published: 16 June 2021
14m 37sPart 2 | Session 2 The DK Crush - Optimised
1h 37m 35s
13m 55sPart 2 | Session 4 Culotte – Optimised
12m 57sPart 2 | Session 5 Recognising and Troubleshooting Bifurcation Complications
19m 57sPart 2 | Session 6 CORE 2021 - Day 1 Wrap-up
15m 25sPart 3 | Session 1 Welcome and Defining Surgical 'Turndowns'
13m 53sPart 3 | Session 2 Day Case PCI – How Can Imaging Help With Safe Discharge?
18m 42sPart 3 | Session 3 The Role of an “Optimising” Procedure in Complex PCI
17m 12sPart 3 | Session 4 Anticipating (& Preventing) Complications in CAC
1h 31m 17sPart 3 | Session 5 LIVE CASES: Surgical Turndown Case and Calcium Modification Case
16m 18sPart 4 | Session 1 Access Site Management
16m 39sPart 4 | Session 2 Modulating Radiation Risk, Stand Back or Stand Clear?
19m 33sPart 4 | Session 3 Metabolic Dysregulation
1h 19m 26s
18m 8sPart 4 | Session 5 CORE 2021 – Day 2: Wrap-up
18m 32sPart 1 | Session 1 Welcome and Angina as a Therapeutic Goal – Redefining Success Evald Høj Christiansen, Thomas Engstrøm, Oskar Angeras, Lene Holmvang, Jonas Persson
14m 29sPart 1 | Session 2 Treating Angina: How to Leverage the Placebo Effect! Rasha Al-Lamee, Evald Høj Christiansen, Thomas Engstrøm, Oskar Angeras, Lene Holmvang, Jonas Persson
21m 39sPart 1 | Session 3 The MDT Discussion – Defining Standards Sarah Clarke, Adrian P Banning, Rasha Al-Lamee, Peter O’Kane, Jonathan Hill
1h 31m 35sPart 1 | Session 4 LIVE CASES: MVD Case Physiology - Defining Target Lesion, Bystander Disease, and INOCA Patient - How to Perform Full Physiology Thomas Engstrøm, Andrew Lucking, Giovanni Luigi De Maria, Jacob Thomsen Lønborg, Evald Høj Christiansen, Lene Holmvang, Jonas Persson, Oskar Angeras, Thomas Engstrøm
14m 21sPart 1 | Session 5 Myocardial Bridge – Physiology and Guide to Assessment and Treatment and Morning Summary Javier Escaned, Evald Høj Christiansen, Lene Holmvang, Jonas Persson, Oskar Angeras
The 5th annual CORE meeting (16 and 17 June 2021) was hosted by Radcliffe Cardiology in collaboration with Optima Education and Abbott Vascular.
The meeting was led by Course Directors Prof Adrian Banning, Prof Evald Christiansen, Dr Jonathan Hill and Prof James Spratt and streamed from our London, Copenhagen, and Dublin hubs.
CORE 2021 focuses on contemporary standards of clinical practice, complex lesion and patient strategies and advanced diagnostic and treatment methods. The goal of CORE is to ensure procedural efficiencies while achieving durable patient outcomes, review patient care beyond intervention and discuss the best practices and innovation outside the catheterisation lab.
More from this programme
CORE 2021 – Day 1: Morning – Physiology
CORE 2021 – Day 1: Afternoon – Bifurcation Management
CORE 2021 – Day 2: Morning – Durable Outcomes
CORE 2021 – Day 2: Afternoon – Beyond Intervention
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.
A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment.
Professor of Interventional Cardiology
Prof James Spratt is a Professor of Interventional cardiology. A high-volume Interventional Cardiologist with an international reputation in complex PCI, with a sub-speciality interest in intravascular imaging and CTO. Widely published within this area and has performed live case demonstrations globally. He is interested in medical education and is the Founder of Optima Education. Prof James Spratt is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
Consultant Cardiologist, Bristol Heart Institute
Dr Johnson is fully trained in percutaneous coronary intervention and all aspects of general cardiology including hypertension, cardiovascular risk assessment, valvular heart disease, heart failure and arrhythmia.
He qualified from St Mary's Hospital (Imperial College, London) in 1998 and prior to commencing specialist training in the South West he undertook a period of research studying novel treatment strategies to prevent re-narrowing of stented coronaries and bypass grafts, culminating in the award of an MD. Additionally, he spent one year as Interventional Fellow at the world renowned Greenlane Cardiovascular Unit in New Zealand.
Adrian P Banning
Prof Adrian Banning is a Consultant Cardiologist, specialising in percutaneous coronary intervention. He works as a Consultant in interventional and general cardiology and is one of the founder members of the Oxford Private Heart and Lung Centre at Nuffield Health Oxford at The Manor Hospital.
He is recognised as one of the UK’s top interventional cardiologists and until recently he was President of the British Cardiac Intervention Society. He performs more than 250 coronary intervention procedures every year and he is an expert in TAVI –implantation of a new aortic valve through a keyhole incision and performs >150 of these TAVI procedures each year.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
St George’s Hospital, London
Claudia Cosgrove is an interventional cardiologist at St George’s Hospital in London, UK.
Freeman Hospital, Newcastle Upon Tyne
Mohaned Egred is a Consultant Cardiologist at the Freeman Hospital, Newcastle Upon Tyne.
Director of Interventional Cardiology
Dr Sean Gallagher is an interventional cardiologist. His interventional training was at The London Chest Hospital before undertaking an overseas fellowship at the Ottawa Heart Institute.
He was appointed as a consultant in 2014 and now works as the Director of Interventional Cardiology at the University Hospital of Wales, Cardiff, UK.
Dr Gallagher’s clinical interest is the interventional management of complex coronary disease, especially chronic total occlusion PCI.